- Home
- MPU vs ALGS Comparison
MPU vs ALGS Comparison
Compare MPU & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- ALGS
- Stock Information
- Founded
- MPU 1989
- ALGS 2018
- Country
- MPU Singapore
- ALGS United States
- Employees
- MPU N/A
- ALGS 70
- Industry
- MPU Transportation Services
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- MPU Consumer Discretionary
- ALGS Health Care
- Exchange
- MPU Nasdaq
- ALGS Nasdaq
- Market Cap
- MPU 31.3M
- ALGS 27.9M
- IPO Year
- MPU 1998
- ALGS 2020
- Fundamental
- Price
- MPU $0.92
- ALGS $5.55
- Analyst Decision
- MPU
- ALGS Strong Buy
- Analyst Count
- MPU 0
- ALGS 1
- Target Price
- MPU N/A
- ALGS $70.00
- AVG Volume (30 Days)
- MPU 62.7K
- ALGS 184.5K
- Earning Date
- MPU 05-07-2025
- ALGS 05-06-2025
- Dividend Yield
- MPU N/A
- ALGS N/A
- EPS Growth
- MPU N/A
- ALGS N/A
- EPS
- MPU N/A
- ALGS N/A
- Revenue
- MPU $36,184,000.00
- ALGS $3,945,000.00
- Revenue This Year
- MPU N/A
- ALGS $580.86
- Revenue Next Year
- MPU N/A
- ALGS N/A
- P/E Ratio
- MPU N/A
- ALGS N/A
- Revenue Growth
- MPU N/A
- ALGS N/A
- 52 Week Low
- MPU $0.49
- ALGS $3.76
- 52 Week High
- MPU $2.69
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- MPU 66.38
- ALGS 34.64
- Support Level
- MPU $0.71
- ALGS $4.33
- Resistance Level
- MPU $0.95
- ALGS $5.94
- Average True Range (ATR)
- MPU 0.08
- ALGS 0.76
- MACD
- MPU 0.03
- ALGS 0.47
- Stochastic Oscillator
- MPU 96.26
- ALGS 71.58
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.